nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—systemic scleroderma—systemic lupus erythematosus	0.41	1	CtDrD
Captopril—F2—systemic lupus erythematosus	0.129	0.399	CbGaD
Captopril—MMP9—systemic lupus erythematosus	0.0992	0.307	CbGaD
Captopril—ACE—systemic lupus erythematosus	0.0673	0.208	CbGaD
Captopril—ALB—systemic lupus erythematosus	0.0276	0.0854	CbGaD
Captopril—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0134	0.125	CbGbCtD
Captopril—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0119	0.111	CbGbCtD
Captopril—ALB—Prednisone—systemic lupus erythematosus	0.0107	0.1	CbGbCtD
Captopril—REN—renal vein—systemic lupus erythematosus	0.00931	0.167	CbGeAlD
Captopril—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00925	0.0864	CbGbCtD
Captopril—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00701	0.0655	CbGbCtD
Captopril—SLC22A6—Methotrexate—systemic lupus erythematosus	0.00631	0.0589	CbGbCtD
Captopril—ABCB1—Betamethasone—systemic lupus erythematosus	0.00602	0.0562	CbGbCtD
Captopril—ABCB1—Prednisolone—systemic lupus erythematosus	0.00594	0.0554	CbGbCtD
Captopril—F2—cardial valve—systemic lupus erythematosus	0.00567	0.102	CbGeAlD
Captopril—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00563	0.0525	CbGbCtD
Captopril—ABCB1—Prednisone—systemic lupus erythematosus	0.00561	0.0523	CbGbCtD
Captopril—ALB—Methotrexate—systemic lupus erythematosus	0.00538	0.0502	CbGbCtD
Captopril—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00531	0.0496	CbGbCtD
Captopril—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00501	0.0467	CbGbCtD
Captopril—MMP9—synovial fluid—systemic lupus erythematosus	0.0036	0.0646	CbGeAlD
Captopril—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0035	0.0327	CbGbCtD
Captopril—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0033	0.0308	CbGbCtD
Captopril—MMP2—tunica intima—systemic lupus erythematosus	0.00328	0.0588	CbGeAlD
Captopril—MMP9—tunica intima—systemic lupus erythematosus	0.00285	0.0512	CbGeAlD
Captopril—ABCB1—Methotrexate—systemic lupus erythematosus	0.00281	0.0263	CbGbCtD
Captopril—REN—urine—systemic lupus erythematosus	0.00175	0.0315	CbGeAlD
Captopril—ACE—tunica intima—systemic lupus erythematosus	0.00152	0.0273	CbGeAlD
Captopril—F2—urine—systemic lupus erythematosus	0.00122	0.022	CbGeAlD
Captopril—MMP2—endothelium—systemic lupus erythematosus	0.000948	0.017	CbGeAlD
Captopril—ACE—umbilical vein—systemic lupus erythematosus	0.000927	0.0166	CbGeAlD
Captopril—REN—blood plasma—systemic lupus erythematosus	0.000916	0.0164	CbGeAlD
Captopril—MMP2—blood plasma—systemic lupus erythematosus	0.000842	0.0151	CbGeAlD
Captopril—MMP9—endothelium—systemic lupus erythematosus	0.000824	0.0148	CbGeAlD
Captopril—ACE—urine—systemic lupus erythematosus	0.000748	0.0134	CbGeAlD
Captopril—MMP9—blood plasma—systemic lupus erythematosus	0.000732	0.0131	CbGeAlD
Captopril—F2—endothelium—systemic lupus erythematosus	0.000719	0.0129	CbGeAlD
Captopril—F2—blood plasma—systemic lupus erythematosus	0.000639	0.0115	CbGeAlD
Captopril—LTA4H—connective tissue—systemic lupus erythematosus	0.000632	0.0113	CbGeAlD
Captopril—LTA4H—nephron tubule—systemic lupus erythematosus	0.000612	0.011	CbGeAlD
Captopril—Enalapril—ACE—systemic lupus erythematosus	0.000539	1	CrCbGaD
Captopril—LTA4H—kidney—systemic lupus erythematosus	0.000538	0.00965	CbGeAlD
Captopril—LTA4H—cortex of kidney—systemic lupus erythematosus	0.000524	0.0094	CbGeAlD
Captopril—REN—connective tissue—systemic lupus erythematosus	0.000487	0.00875	CbGeAlD
Captopril—REN—nephron tubule—systemic lupus erythematosus	0.000472	0.00847	CbGeAlD
Captopril—LTA4H—lymphoid tissue—systemic lupus erythematosus	0.000462	0.00829	CbGeAlD
Captopril—MMP2—connective tissue—systemic lupus erythematosus	0.000448	0.00804	CbGeAlD
Captopril—ACE—endothelium—systemic lupus erythematosus	0.000439	0.00788	CbGeAlD
Captopril—LTA4H—tendon—systemic lupus erythematosus	0.000434	0.00779	CbGeAlD
Captopril—LTA4H—bone marrow—systemic lupus erythematosus	0.00042	0.00755	CbGeAlD
Captopril—REN—kidney—systemic lupus erythematosus	0.000415	0.00745	CbGeAlD
Captopril—MMP2—skin of body—systemic lupus erythematosus	0.000405	0.00726	CbGeAlD
Captopril—REN—cortex of kidney—systemic lupus erythematosus	0.000404	0.00725	CbGeAlD
Captopril—ACE—blood plasma—systemic lupus erythematosus	0.00039	0.007	CbGeAlD
Captopril—MMP9—connective tissue—systemic lupus erythematosus	0.00039	0.00699	CbGeAlD
Captopril—MMP2—kidney—systemic lupus erythematosus	0.000381	0.00685	CbGeAlD
Captopril—LTA4H—lung—systemic lupus erythematosus	0.000381	0.00684	CbGeAlD
Captopril—MMP2—cortex of kidney—systemic lupus erythematosus	0.000372	0.00667	CbGeAlD
Captopril—CYP2D6—urine—systemic lupus erythematosus	0.000366	0.00657	CbGeAlD
Captopril—LTA4H—nervous system—systemic lupus erythematosus	0.000353	0.00633	CbGeAlD
Captopril—MMP9—skin of body—systemic lupus erythematosus	0.000352	0.00631	CbGeAlD
Captopril—F2—connective tissue—systemic lupus erythematosus	0.00034	0.0061	CbGeAlD
Captopril—LTA4H—central nervous system—systemic lupus erythematosus	0.00034	0.00609	CbGeAlD
Captopril—SLC22A6—nephron tubule—systemic lupus erythematosus	0.000337	0.00605	CbGeAlD
Captopril—MMP9—kidney—systemic lupus erythematosus	0.000332	0.00595	CbGeAlD
Captopril—MMP2—lymphoid tissue—systemic lupus erythematosus	0.000328	0.00588	CbGeAlD
Captopril—MMP2—tendon—systemic lupus erythematosus	0.000308	0.00553	CbGeAlD
Captopril—REN—lung—systemic lupus erythematosus	0.000294	0.00528	CbGeAlD
Captopril—F2—kidney—systemic lupus erythematosus	0.000289	0.00519	CbGeAlD
Captopril—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000289	0.00518	CbGeAlD
Captopril—MMP9—lymphoid tissue—systemic lupus erythematosus	0.000285	0.00511	CbGeAlD
Captopril—SLC15A1—nephron tubule—systemic lupus erythematosus	0.000281	0.00504	CbGeAlD
Captopril—REN—nervous system—systemic lupus erythematosus	0.000272	0.00489	CbGeAlD
Captopril—MMP2—lung—systemic lupus erythematosus	0.00027	0.00485	CbGeAlD
Captopril—MMP9—tendon—systemic lupus erythematosus	0.000268	0.00481	CbGeAlD
Captopril—REN—central nervous system—systemic lupus erythematosus	0.000262	0.0047	CbGeAlD
Captopril—MMP9—bone marrow—systemic lupus erythematosus	0.000259	0.00466	CbGeAlD
Captopril—MMP2—nervous system—systemic lupus erythematosus	0.00025	0.00449	CbGeAlD
Captopril—F2—lymphoid tissue—systemic lupus erythematosus	0.000249	0.00446	CbGeAlD
Captopril—SLC15A1—kidney—systemic lupus erythematosus	0.000247	0.00443	CbGeAlD
Captopril—MMP2—central nervous system—systemic lupus erythematosus	0.000241	0.00432	CbGeAlD
Captopril—MMP9—lung—systemic lupus erythematosus	0.000235	0.00422	CbGeAlD
Captopril—F2—bone marrow—systemic lupus erythematosus	0.000226	0.00406	CbGeAlD
Captopril—MMP9—nervous system—systemic lupus erythematosus	0.000218	0.00391	CbGeAlD
Captopril—MMP9—central nervous system—systemic lupus erythematosus	0.00021	0.00376	CbGeAlD
Captopril—ACE—connective tissue—systemic lupus erythematosus	0.000208	0.00373	CbGeAlD
Captopril—F2—lung—systemic lupus erythematosus	0.000205	0.00368	CbGeAlD
Captopril—ACE—nephron tubule—systemic lupus erythematosus	0.000201	0.00361	CbGeAlD
Captopril—CYP2D6—blood plasma—systemic lupus erythematosus	0.000191	0.00343	CbGeAlD
Captopril—F2—nervous system—systemic lupus erythematosus	0.00019	0.00341	CbGeAlD
Captopril—F2—central nervous system—systemic lupus erythematosus	0.000183	0.00328	CbGeAlD
Captopril—ACE—kidney—systemic lupus erythematosus	0.000177	0.00317	CbGeAlD
Captopril—ACE—cortex of kidney—systemic lupus erythematosus	0.000172	0.00309	CbGeAlD
Captopril—ACE—lymphoid tissue—systemic lupus erythematosus	0.000152	0.00273	CbGeAlD
Captopril—ACE—bone marrow—systemic lupus erythematosus	0.000138	0.00248	CbGeAlD
Captopril—ABCB1—blood plasma—systemic lupus erythematosus	0.000137	0.00246	CbGeAlD
Captopril—ACE—lung—systemic lupus erythematosus	0.000125	0.00225	CbGeAlD
Captopril—MMP2—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.00012	0.0912	CbGdCrCtD
Captopril—MMP2—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.00012	0.0912	CbGdCrCtD
Captopril—ACE—nervous system—systemic lupus erythematosus	0.000116	0.00208	CbGeAlD
Captopril—MMP2—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000113	0.0861	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000113	0.0861	CbGdCrCtD
Captopril—ACE—central nervous system—systemic lupus erythematosus	0.000112	0.002	CbGeAlD
Captopril—MMP2—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000111	0.0847	CbGdCrCtD
Captopril—MMP2—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000111	0.0847	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000109	0.0828	CbGdCrCtD
Captopril—MMP2—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000109	0.0828	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisone—systemic lupus erythematosus	0.000103	0.0786	CbGdCrCtD
Captopril—MMP2—Betamethasone—Prednisone—systemic lupus erythematosus	0.000103	0.0786	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.000101	0.0767	CbGdCrCtD
Captopril—MMP2—Betamethasone—Prednisolone—systemic lupus erythematosus	0.000101	0.0767	CbGdCrCtD
Captopril—CYP2D6—kidney—systemic lupus erythematosus	8.65e-05	0.00155	CbGeAlD
Captopril—ABCB1—nephron tubule—systemic lupus erythematosus	7.08e-05	0.00127	CbGeAlD
Captopril—ABCB1—kidney—systemic lupus erythematosus	6.22e-05	0.00112	CbGeAlD
Captopril—ABCB1—cortex of kidney—systemic lupus erythematosus	6.06e-05	0.00109	CbGeAlD
Captopril—CYP2D6—nervous system—systemic lupus erythematosus	5.68e-05	0.00102	CbGeAlD
Captopril—CYP2D6—central nervous system—systemic lupus erythematosus	5.47e-05	0.000981	CbGeAlD
Captopril—ABCB1—lymphoid tissue—systemic lupus erythematosus	5.35e-05	0.000959	CbGeAlD
Captopril—ABCB1—bone marrow—systemic lupus erythematosus	4.87e-05	0.000874	CbGeAlD
Captopril—Headache—Azathioprine—systemic lupus erythematosus	4.84e-05	0.000832	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	4.83e-05	0.000831	CcSEcCtD
Captopril—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	4.83e-05	0.000831	CcSEcCtD
Captopril—Dizziness—Leflunomide—systemic lupus erythematosus	4.82e-05	0.000829	CcSEcCtD
Captopril—Constipation—Cyclosporine—systemic lupus erythematosus	4.81e-05	0.000828	CcSEcCtD
Captopril—Dry mouth—Triamcinolone—systemic lupus erythematosus	4.8e-05	0.000826	CcSEcCtD
Captopril—Renal failure—Methotrexate—systemic lupus erythematosus	4.79e-05	0.000824	CcSEcCtD
Captopril—Angioedema—Betamethasone—systemic lupus erythematosus	4.78e-05	0.000823	CcSEcCtD
Captopril—Angioedema—Dexamethasone—systemic lupus erythematosus	4.78e-05	0.000823	CcSEcCtD
Captopril—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	4.77e-05	0.000821	CcSEcCtD
Captopril—Anorexia—Hydrocortisone—systemic lupus erythematosus	4.77e-05	0.00082	CcSEcCtD
Captopril—Stomatitis—Methotrexate—systemic lupus erythematosus	4.75e-05	0.000817	CcSEcCtD
Captopril—Confusional state—Methylprednisolone—systemic lupus erythematosus	4.74e-05	0.000815	CcSEcCtD
Captopril—Malaise—Betamethasone—systemic lupus erythematosus	4.72e-05	0.000812	CcSEcCtD
Captopril—Malaise—Dexamethasone—systemic lupus erythematosus	4.72e-05	0.000812	CcSEcCtD
Captopril—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	4.71e-05	0.00081	CcSEcCtD
Captopril—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	4.7e-05	0.000808	CcSEcCtD
Captopril—Syncope—Betamethasone—systemic lupus erythematosus	4.69e-05	0.000807	CcSEcCtD
Captopril—Syncope—Dexamethasone—systemic lupus erythematosus	4.69e-05	0.000807	CcSEcCtD
Captopril—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	4.69e-05	0.000807	CcSEcCtD
Captopril—Hypotension—Hydrocortisone—systemic lupus erythematosus	4.67e-05	0.000804	CcSEcCtD
Captopril—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	4.64e-05	0.000798	CcSEcCtD
Captopril—Vomiting—Leflunomide—systemic lupus erythematosus	4.63e-05	0.000797	CcSEcCtD
Captopril—Shock—Triamcinolone—systemic lupus erythematosus	4.63e-05	0.000797	CcSEcCtD
Captopril—Insomnia—Prednisolone—systemic lupus erythematosus	4.63e-05	0.000797	CcSEcCtD
Captopril—Alopecia—Prednisone—systemic lupus erythematosus	4.63e-05	0.000796	CcSEcCtD
Captopril—Shock—Methylprednisolone—systemic lupus erythematosus	4.62e-05	0.000795	CcSEcCtD
Captopril—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	4.6e-05	0.000791	CcSEcCtD
Captopril—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	4.6e-05	0.000791	CcSEcCtD
Captopril—Loss of consciousness—Betamethasone—systemic lupus erythematosus	4.6e-05	0.000791	CcSEcCtD
Captopril—Paraesthesia—Prednisolone—systemic lupus erythematosus	4.6e-05	0.000791	CcSEcCtD
Captopril—Rash—Leflunomide—systemic lupus erythematosus	4.6e-05	0.000791	CcSEcCtD
Captopril—Tachycardia—Triamcinolone—systemic lupus erythematosus	4.59e-05	0.00079	CcSEcCtD
Captopril—Dermatitis—Leflunomide—systemic lupus erythematosus	4.59e-05	0.00079	CcSEcCtD
Captopril—Nausea—Azathioprine—systemic lupus erythematosus	4.58e-05	0.000789	CcSEcCtD
Captopril—Tachycardia—Methylprednisolone—systemic lupus erythematosus	4.58e-05	0.000789	CcSEcCtD
Captopril—Headache—Leflunomide—systemic lupus erythematosus	4.57e-05	0.000786	CcSEcCtD
Captopril—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	4.55e-05	0.000784	CcSEcCtD
Captopril—Agranulocytosis—Methotrexate—systemic lupus erythematosus	4.55e-05	0.000783	CcSEcCtD
Captopril—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	4.52e-05	0.000778	CcSEcCtD
Captopril—Insomnia—Hydrocortisone—systemic lupus erythematosus	4.52e-05	0.000778	CcSEcCtD
Captopril—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	4.49e-05	0.000772	CcSEcCtD
Captopril—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.49e-05	0.000772	CcSEcCtD
Captopril—Myalgia—Dexamethasone—systemic lupus erythematosus	4.46e-05	0.000767	CcSEcCtD
Captopril—Myalgia—Betamethasone—systemic lupus erythematosus	4.46e-05	0.000767	CcSEcCtD
Captopril—Abdominal pain—Cyclosporine—systemic lupus erythematosus	4.45e-05	0.000765	CcSEcCtD
Captopril—Body temperature increased—Cyclosporine—systemic lupus erythematosus	4.45e-05	0.000765	CcSEcCtD
Captopril—ABCB1—lung—systemic lupus erythematosus	4.41e-05	0.000792	CbGeAlD
Captopril—Discomfort—Betamethasone—systemic lupus erythematosus	4.4e-05	0.000757	CcSEcCtD
Captopril—Discomfort—Dexamethasone—systemic lupus erythematosus	4.4e-05	0.000757	CcSEcCtD
Captopril—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	4.4e-05	0.000757	CcSEcCtD
Captopril—Hypotension—Methylprednisolone—systemic lupus erythematosus	4.39e-05	0.000755	CcSEcCtD
Captopril—Hepatitis—Methotrexate—systemic lupus erythematosus	4.38e-05	0.000753	CcSEcCtD
Captopril—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.35e-05	0.000748	CcSEcCtD
Captopril—Pharyngitis—Methotrexate—systemic lupus erythematosus	4.34e-05	0.000747	CcSEcCtD
Captopril—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.34e-05	0.000746	CcSEcCtD
Captopril—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.34e-05	0.000746	CcSEcCtD
Captopril—Nausea—Leflunomide—systemic lupus erythematosus	4.33e-05	0.000745	CcSEcCtD
Captopril—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.31e-05	0.000742	CcSEcCtD
Captopril—Vision blurred—Prednisone—systemic lupus erythematosus	4.3e-05	0.000739	CcSEcCtD
Captopril—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.29e-05	0.000738	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.28e-05	0.000736	CcSEcCtD
Captopril—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	4.27e-05	0.000735	CcSEcCtD
Captopril—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	4.27e-05	0.000735	CcSEcCtD
Captopril—Insomnia—Triamcinolone—systemic lupus erythematosus	4.26e-05	0.000732	CcSEcCtD
Captopril—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.25e-05	0.000731	CcSEcCtD
Captopril—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.23e-05	0.000728	CcSEcCtD
Captopril—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.23e-05	0.000727	CcSEcCtD
Captopril—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.22e-05	0.000726	CcSEcCtD
Captopril—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.22e-05	0.000726	CcSEcCtD
Captopril—Anaemia—Prednisone—systemic lupus erythematosus	4.21e-05	0.000725	CcSEcCtD
Captopril—Shock—Betamethasone—systemic lupus erythematosus	4.2e-05	0.000723	CcSEcCtD
Captopril—Shock—Dexamethasone—systemic lupus erythematosus	4.2e-05	0.000723	CcSEcCtD
Captopril—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.2e-05	0.000722	CcSEcCtD
Captopril—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.18e-05	0.000719	CcSEcCtD
Captopril—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.18e-05	0.000719	CcSEcCtD
Captopril—Tachycardia—Betamethasone—systemic lupus erythematosus	4.17e-05	0.000717	CcSEcCtD
Captopril—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.17e-05	0.000717	CcSEcCtD
Captopril—Angioedema—Prednisone—systemic lupus erythematosus	4.16e-05	0.000716	CcSEcCtD
Captopril—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.14e-05	0.000713	CcSEcCtD
Captopril—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.14e-05	0.000712	CcSEcCtD
Captopril—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.13e-05	0.000711	CcSEcCtD
Captopril—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.12e-05	0.000709	CcSEcCtD
Captopril—Malaise—Prednisone—systemic lupus erythematosus	4.11e-05	0.000707	CcSEcCtD
Captopril—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.09e-05	0.000703	CcSEcCtD
Captopril—Syncope—Prednisone—systemic lupus erythematosus	4.09e-05	0.000703	CcSEcCtD
Captopril—ABCB1—nervous system—systemic lupus erythematosus	4.08e-05	0.000733	CbGeAlD
Captopril—Anorexia—Betamethasone—systemic lupus erythematosus	4.07e-05	0.0007	CcSEcCtD
Captopril—Anorexia—Dexamethasone—systemic lupus erythematosus	4.07e-05	0.0007	CcSEcCtD
Captopril—Fatigue—Triamcinolone—systemic lupus erythematosus	4.06e-05	0.000698	CcSEcCtD
Captopril—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.05e-05	0.000697	CcSEcCtD
Captopril—Asthenia—Cyclosporine—systemic lupus erythematosus	4.04e-05	0.000694	CcSEcCtD
Captopril—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.01e-05	0.000689	CcSEcCtD
Captopril—Hypotension—Dexamethasone—systemic lupus erythematosus	3.99e-05	0.000687	CcSEcCtD
Captopril—Hypotension—Betamethasone—systemic lupus erythematosus	3.99e-05	0.000687	CcSEcCtD
Captopril—Pruritus—Cyclosporine—systemic lupus erythematosus	3.98e-05	0.000685	CcSEcCtD
Captopril—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.95e-05	0.00068	CcSEcCtD
Captopril—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.95e-05	0.00068	CcSEcCtD
Captopril—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.94e-05	0.000677	CcSEcCtD
Captopril—ABCB1—central nervous system—systemic lupus erythematosus	3.93e-05	0.000706	CbGeAlD
Captopril—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.89e-05	0.000669	CcSEcCtD
Captopril—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.89e-05	0.000669	CcSEcCtD
Captopril—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.88e-05	0.000668	CcSEcCtD
Captopril—Arthralgia—Prednisone—systemic lupus erythematosus	3.88e-05	0.000668	CcSEcCtD
Captopril—Myalgia—Prednisone—systemic lupus erythematosus	3.88e-05	0.000668	CcSEcCtD
Captopril—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	3.88e-05	0.000667	CcSEcCtD
Captopril—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	3.87e-05	0.000666	CcSEcCtD
Captopril—Alopecia—Methotrexate—systemic lupus erythematosus	3.87e-05	0.000665	CcSEcCtD
Captopril—Insomnia—Dexamethasone—systemic lupus erythematosus	3.86e-05	0.000665	CcSEcCtD
Captopril—Insomnia—Betamethasone—systemic lupus erythematosus	3.86e-05	0.000665	CcSEcCtD
Captopril—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.85e-05	0.000662	CcSEcCtD
Captopril—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.84e-05	0.000661	CcSEcCtD
Captopril—Paraesthesia—Betamethasone—systemic lupus erythematosus	3.84e-05	0.00066	CcSEcCtD
Captopril—Paraesthesia—Dexamethasone—systemic lupus erythematosus	3.84e-05	0.00066	CcSEcCtD
Captopril—Discomfort—Prednisone—systemic lupus erythematosus	3.83e-05	0.00066	CcSEcCtD
Captopril—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.76e-05	0.000647	CcSEcCtD
Captopril—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.76e-05	0.000647	CcSEcCtD
Captopril—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.75e-05	0.000646	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—systemic lupus erythematosus	3.73e-05	0.000642	CcSEcCtD
Captopril—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.72e-05	0.00064	CcSEcCtD
Captopril—Dizziness—Cyclosporine—systemic lupus erythematosus	3.72e-05	0.00064	CcSEcCtD
Captopril—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.72e-05	0.00064	CcSEcCtD
Captopril—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.71e-05	0.000639	CcSEcCtD
Captopril—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.71e-05	0.000639	CcSEcCtD
Captopril—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.71e-05	0.000639	CcSEcCtD
Captopril—Fatigue—Betamethasone—systemic lupus erythematosus	3.68e-05	0.000634	CcSEcCtD
Captopril—Fatigue—Dexamethasone—systemic lupus erythematosus	3.68e-05	0.000634	CcSEcCtD
Captopril—Shock—Prednisone—systemic lupus erythematosus	3.66e-05	0.00063	CcSEcCtD
Captopril—Tachycardia—Prednisone—systemic lupus erythematosus	3.63e-05	0.000625	CcSEcCtD
Captopril—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.63e-05	0.000624	CcSEcCtD
Captopril—Vision blurred—Methotrexate—systemic lupus erythematosus	3.59e-05	0.000618	CcSEcCtD
Captopril—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.59e-05	0.000617	CcSEcCtD
Captopril—Vomiting—Cyclosporine—systemic lupus erythematosus	3.58e-05	0.000615	CcSEcCtD
Captopril—Rash—Cyclosporine—systemic lupus erythematosus	3.55e-05	0.00061	CcSEcCtD
Captopril—Anorexia—Prednisone—systemic lupus erythematosus	3.55e-05	0.00061	CcSEcCtD
Captopril—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.54e-05	0.00061	CcSEcCtD
Captopril—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.54e-05	0.000609	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000608	CcSEcCtD
Captopril—Headache—Cyclosporine—systemic lupus erythematosus	3.52e-05	0.000606	CcSEcCtD
Captopril—Anaemia—Methotrexate—systemic lupus erythematosus	3.52e-05	0.000606	CcSEcCtD
Captopril—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.52e-05	0.000606	CcSEcCtD
Captopril—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.52e-05	0.000606	CcSEcCtD
Captopril—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.49e-05	0.000601	CcSEcCtD
Captopril—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.49e-05	0.000601	CcSEcCtD
Captopril—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.49e-05	0.0006	CcSEcCtD
Captopril—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.46e-05	0.000595	CcSEcCtD
Captopril—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.46e-05	0.000595	CcSEcCtD
Captopril—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.44e-05	0.000591	CcSEcCtD
Captopril—Malaise—Methotrexate—systemic lupus erythematosus	3.43e-05	0.000591	CcSEcCtD
Captopril—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.42e-05	0.000588	CcSEcCtD
Captopril—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.39e-05	0.000583	CcSEcCtD
Captopril—Dizziness—Prednisolone—systemic lupus erythematosus	3.38e-05	0.000582	CcSEcCtD
Captopril—Asthenia—Triamcinolone—systemic lupus erythematosus	3.38e-05	0.000581	CcSEcCtD
Captopril—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.38e-05	0.000581	CcSEcCtD
Captopril—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.38e-05	0.000581	CcSEcCtD
Captopril—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.38e-05	0.000581	CcSEcCtD
Captopril—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.38e-05	0.000581	CcSEcCtD
Captopril—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.37e-05	0.00058	CcSEcCtD
Captopril—Insomnia—Prednisone—systemic lupus erythematosus	3.36e-05	0.000579	CcSEcCtD
Captopril—Nausea—Cyclosporine—systemic lupus erythematosus	3.34e-05	0.000575	CcSEcCtD
Captopril—Paraesthesia—Prednisone—systemic lupus erythematosus	3.34e-05	0.000575	CcSEcCtD
Captopril—Pruritus—Triamcinolone—systemic lupus erythematosus	3.33e-05	0.000573	CcSEcCtD
Captopril—Cough—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000572	CcSEcCtD
Captopril—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.32e-05	0.000572	CcSEcCtD
Captopril—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.31e-05	0.000569	CcSEcCtD
Captopril—Dyspepsia—Prednisone—systemic lupus erythematosus	3.27e-05	0.000563	CcSEcCtD
Captopril—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.26e-05	0.000561	CcSEcCtD
Captopril—Arthralgia—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000558	CcSEcCtD
Captopril—Chest pain—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000558	CcSEcCtD
Captopril—Myalgia—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000558	CcSEcCtD
Captopril—Decreased appetite—Prednisone—systemic lupus erythematosus	3.23e-05	0.000556	CcSEcCtD
Captopril—Rash—Prednisolone—systemic lupus erythematosus	3.23e-05	0.000555	CcSEcCtD
Captopril—Dermatitis—Prednisolone—systemic lupus erythematosus	3.22e-05	0.000555	CcSEcCtD
Captopril—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.21e-05	0.000553	CcSEcCtD
Captopril—Fatigue—Prednisone—systemic lupus erythematosus	3.21e-05	0.000552	CcSEcCtD
Captopril—Headache—Prednisolone—systemic lupus erythematosus	3.21e-05	0.000552	CcSEcCtD
Captopril—Discomfort—Methotrexate—systemic lupus erythematosus	3.2e-05	0.000551	CcSEcCtD
Captopril—Constipation—Prednisone—systemic lupus erythematosus	3.18e-05	0.000547	CcSEcCtD
Captopril—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.18e-05	0.000547	CcSEcCtD
Captopril—Rash—Hydrocortisone—systemic lupus erythematosus	3.15e-05	0.000542	CcSEcCtD
Captopril—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.15e-05	0.000542	CcSEcCtD
Captopril—Confusional state—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000539	CcSEcCtD
Captopril—Headache—Hydrocortisone—systemic lupus erythematosus	3.13e-05	0.000539	CcSEcCtD
Captopril—Dizziness—Triamcinolone—systemic lupus erythematosus	3.11e-05	0.000536	CcSEcCtD
Captopril—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000535	CcSEcCtD
Captopril—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.11e-05	0.000534	CcSEcCtD
Captopril—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.07e-05	0.000527	CcSEcCtD
Captopril—Asthenia—Dexamethasone—systemic lupus erythematosus	3.06e-05	0.000527	CcSEcCtD
Captopril—Asthenia—Betamethasone—systemic lupus erythematosus	3.06e-05	0.000527	CcSEcCtD
Captopril—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000524	CcSEcCtD
Captopril—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.04e-05	0.000523	CcSEcCtD
Captopril—Nausea—Prednisolone—systemic lupus erythematosus	3.04e-05	0.000523	CcSEcCtD
Captopril—Pruritus—Dexamethasone—systemic lupus erythematosus	3.02e-05	0.00052	CcSEcCtD
Captopril—Pruritus—Betamethasone—systemic lupus erythematosus	3.02e-05	0.00052	CcSEcCtD
Captopril—Vomiting—Triamcinolone—systemic lupus erythematosus	2.99e-05	0.000515	CcSEcCtD
Captopril—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.99e-05	0.000514	CcSEcCtD
Captopril—Nausea—Hydrocortisone—systemic lupus erythematosus	2.97e-05	0.000511	CcSEcCtD
Captopril—Rash—Triamcinolone—systemic lupus erythematosus	2.97e-05	0.000511	CcSEcCtD
Captopril—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.97e-05	0.00051	CcSEcCtD
Captopril—Anorexia—Methotrexate—systemic lupus erythematosus	2.96e-05	0.00051	CcSEcCtD
Captopril—Rash—Methylprednisolone—systemic lupus erythematosus	2.96e-05	0.000509	CcSEcCtD
Captopril—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.96e-05	0.000509	CcSEcCtD
Captopril—Headache—Triamcinolone—systemic lupus erythematosus	2.95e-05	0.000507	CcSEcCtD
Captopril—Headache—Methylprednisolone—systemic lupus erythematosus	2.94e-05	0.000506	CcSEcCtD
Captopril—Body temperature increased—Prednisone—systemic lupus erythematosus	2.94e-05	0.000506	CcSEcCtD
Captopril—Abdominal pain—Prednisone—systemic lupus erythematosus	2.94e-05	0.000506	CcSEcCtD
Captopril—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.92e-05	0.000503	CcSEcCtD
Captopril—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.92e-05	0.000503	CcSEcCtD
Captopril—Hypotension—Methotrexate—systemic lupus erythematosus	2.9e-05	0.0005	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.83e-05	0.000487	CcSEcCtD
Captopril—Dizziness—Betamethasone—systemic lupus erythematosus	2.82e-05	0.000486	CcSEcCtD
Captopril—Dizziness—Dexamethasone—systemic lupus erythematosus	2.82e-05	0.000486	CcSEcCtD
Captopril—Insomnia—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000484	CcSEcCtD
Captopril—Nausea—Triamcinolone—systemic lupus erythematosus	2.8e-05	0.000481	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—systemic lupus erythematosus	2.79e-05	0.00048	CcSEcCtD
Captopril—Nausea—Methylprednisolone—systemic lupus erythematosus	2.79e-05	0.00048	CcSEcCtD
Captopril—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.77e-05	0.000477	CcSEcCtD
Captopril—Somnolence—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000475	CcSEcCtD
Captopril—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.74e-05	0.000471	CcSEcCtD
Captopril—Vomiting—Dexamethasone—systemic lupus erythematosus	2.72e-05	0.000467	CcSEcCtD
Captopril—Vomiting—Betamethasone—systemic lupus erythematosus	2.72e-05	0.000467	CcSEcCtD
Captopril—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.7e-05	0.000465	CcSEcCtD
Captopril—Rash—Betamethasone—systemic lupus erythematosus	2.69e-05	0.000463	CcSEcCtD
Captopril—Rash—Dexamethasone—systemic lupus erythematosus	2.69e-05	0.000463	CcSEcCtD
Captopril—Dermatitis—Betamethasone—systemic lupus erythematosus	2.69e-05	0.000463	CcSEcCtD
Captopril—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.69e-05	0.000463	CcSEcCtD
Captopril—Fatigue—Methotrexate—systemic lupus erythematosus	2.68e-05	0.000461	CcSEcCtD
Captopril—Headache—Betamethasone—systemic lupus erythematosus	2.68e-05	0.00046	CcSEcCtD
Captopril—Headache—Dexamethasone—systemic lupus erythematosus	2.68e-05	0.00046	CcSEcCtD
Captopril—Asthenia—Prednisone—systemic lupus erythematosus	2.67e-05	0.000459	CcSEcCtD
Captopril—Pruritus—Prednisone—systemic lupus erythematosus	2.63e-05	0.000453	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	2.57e-05	0.000577	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	2.56e-05	0.000575	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	2.56e-05	0.000575	CbGpPWpGaD
Captopril—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.56e-05	0.000441	CcSEcCtD
Captopril—ALB—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2.56e-05	0.000573	CbGpPWpGaD
Captopril—Diarrhoea—Prednisone—systemic lupus erythematosus	2.54e-05	0.000438	CcSEcCtD
Captopril—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.54e-05	0.000437	CcSEcCtD
Captopril—Nausea—Betamethasone—systemic lupus erythematosus	2.54e-05	0.000436	CcSEcCtD
Captopril—Nausea—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.000436	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	2.53e-05	0.000567	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	2.52e-05	0.000565	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—RXRA—systemic lupus erythematosus	2.5e-05	0.000561	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	2.49e-05	0.000559	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	2.46e-05	0.000552	CbGpPWpGaD
Captopril—Dizziness—Prednisone—systemic lupus erythematosus	2.46e-05	0.000423	CcSEcCtD
Captopril—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.46e-05	0.000423	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.46e-05	0.000423	CcSEcCtD
Captopril—ALB—Vitamin B12 Metabolism—IFNG—systemic lupus erythematosus	2.44e-05	0.000548	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—PPARG—systemic lupus erythematosus	2.41e-05	0.00054	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	2.38e-05	0.000534	CbGpPWpGaD
Captopril—Vomiting—Prednisone—systemic lupus erythematosus	2.36e-05	0.000407	CcSEcCtD
Captopril—Rash—Prednisone—systemic lupus erythematosus	2.35e-05	0.000403	CcSEcCtD
Captopril—Dermatitis—Prednisone—systemic lupus erythematosus	2.34e-05	0.000403	CcSEcCtD
Captopril—ALB—Folate Metabolism—CCL2—systemic lupus erythematosus	2.34e-05	0.000524	CbGpPWpGaD
Captopril—Headache—Prednisone—systemic lupus erythematosus	2.33e-05	0.000401	CcSEcCtD
Captopril—MMP2—Axon guidance—MMP9—systemic lupus erythematosus	2.33e-05	0.000522	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PPARG—systemic lupus erythematosus	2.33e-05	0.000522	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	2.32e-05	0.00052	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	2.3e-05	0.000515	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	2.28e-05	0.000512	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	2.26e-05	0.000508	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	2.26e-05	0.000507	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	2.26e-05	0.000506	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2.24e-05	0.000502	CbGpPWpGaD
Captopril—Asthenia—Methotrexate—systemic lupus erythematosus	2.23e-05	0.000384	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	2.22e-05	0.000497	CbGpPWpGaD
Captopril—Nausea—Prednisone—systemic lupus erythematosus	2.21e-05	0.00038	CcSEcCtD
Captopril—Pruritus—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000378	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	2.17e-05	0.000486	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL6—systemic lupus erythematosus	2.13e-05	0.000477	CbGpPWpGaD
Captopril—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.13e-05	0.000366	CcSEcCtD
Captopril—MMP2—Developmental Biology—TYK2—systemic lupus erythematosus	2.11e-05	0.000473	CbGpPWpGaD
Captopril—F2—Hemostasis—IFNA1—systemic lupus erythematosus	2.11e-05	0.000473	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	2.11e-05	0.000472	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—JAK1—systemic lupus erythematosus	2.1e-05	0.000472	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ALB—systemic lupus erythematosus	2.09e-05	0.000469	CbGpPWpGaD
Captopril—MMP2—Axon guidance—VEGFA—systemic lupus erythematosus	2.09e-05	0.000469	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	2.09e-05	0.000468	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.08e-05	0.000467	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	2.08e-05	0.000466	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.08e-05	0.000466	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	2.07e-05	0.000464	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	2.06e-05	0.000463	CbGpPWpGaD
Captopril—Dizziness—Methotrexate—systemic lupus erythematosus	2.06e-05	0.000354	CcSEcCtD
Captopril—F2—Hemostasis—RASGRP1—systemic lupus erythematosus	2.05e-05	0.000461	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—F2—systemic lupus erythematosus	2.01e-05	0.000451	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	2.01e-05	0.00045	CbGpPWpGaD
Captopril—LTA4H—Metabolism—NOS3—systemic lupus erythematosus	2e-05	0.000449	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IFNG—systemic lupus erythematosus	1.99e-05	0.000445	CbGpPWpGaD
Captopril—Vomiting—Methotrexate—systemic lupus erythematosus	1.98e-05	0.00034	CcSEcCtD
Captopril—Rash—Methotrexate—systemic lupus erythematosus	1.96e-05	0.000337	CcSEcCtD
Captopril—Dermatitis—Methotrexate—systemic lupus erythematosus	1.96e-05	0.000337	CcSEcCtD
Captopril—Headache—Methotrexate—systemic lupus erythematosus	1.95e-05	0.000335	CcSEcCtD
Captopril—MMP9—Axon guidance—TYK2—systemic lupus erythematosus	1.94e-05	0.000435	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	1.91e-05	0.000428	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.88e-05	0.000422	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	1.88e-05	0.000421	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	1.86e-05	0.000416	CbGpPWpGaD
Captopril—Nausea—Methotrexate—systemic lupus erythematosus	1.85e-05	0.000318	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—IL6—systemic lupus erythematosus	1.84e-05	0.000414	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—systemic lupus erythematosus	1.83e-05	0.00041	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—F2—systemic lupus erythematosus	1.81e-05	0.000406	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CCL2—systemic lupus erythematosus	1.79e-05	0.000402	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL2—systemic lupus erythematosus	1.76e-05	0.000396	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ACE—systemic lupus erythematosus	1.74e-05	0.00039	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	1.74e-05	0.00039	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	1.69e-05	0.00038	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	1.69e-05	0.000379	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCR5—systemic lupus erythematosus	1.69e-05	0.000379	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.69e-05	0.000378	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MMP9—systemic lupus erythematosus	1.66e-05	0.000373	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—C3—systemic lupus erythematosus	1.65e-05	0.00037	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	1.64e-05	0.000367	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CCL2—systemic lupus erythematosus	1.61e-05	0.000362	CbGpPWpGaD
Captopril—F2—Hemostasis—JAK1—systemic lupus erythematosus	1.59e-05	0.000357	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	1.58e-05	0.000355	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	1.58e-05	0.000354	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—PPARG—systemic lupus erythematosus	1.58e-05	0.000354	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.58e-05	0.000354	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EP300—systemic lupus erythematosus	1.57e-05	0.000353	CbGpPWpGaD
Captopril—LTA4H—Metabolism—EP300—systemic lupus erythematosus	1.52e-05	0.000341	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	1.51e-05	0.000339	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	1.51e-05	0.000338	CbGpPWpGaD
Captopril—ALB—Hemostasis—ITGAX—systemic lupus erythematosus	1.5e-05	0.000337	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—VEGFA—systemic lupus erythematosus	1.49e-05	0.000335	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2RA—systemic lupus erythematosus	1.49e-05	0.000334	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TLR9—systemic lupus erythematosus	1.48e-05	0.000333	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	1.48e-05	0.000332	CbGpPWpGaD
Captopril—ALB—Hemostasis—F3—systemic lupus erythematosus	1.48e-05	0.000332	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	1.47e-05	0.00033	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—systemic lupus erythematosus	1.45e-05	0.000324	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	1.44e-05	0.000322	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.44e-05	0.000322	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	1.44e-05	0.000322	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.4e-05	0.000314	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	1.39e-05	0.000312	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	1.39e-05	0.000311	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TYK2—systemic lupus erythematosus	1.38e-05	0.00031	CbGpPWpGaD
Captopril—MMP9—Axon guidance—VEGFA—systemic lupus erythematosus	1.37e-05	0.000308	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—systemic lupus erythematosus	1.37e-05	0.000307	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.36e-05	0.000304	CbGpPWpGaD
Captopril—ALB—Hemostasis—CLU—systemic lupus erythematosus	1.34e-05	0.000301	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	1.34e-05	0.0003	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CSK—systemic lupus erythematosus	1.32e-05	0.000297	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	1.32e-05	0.000296	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	1.31e-05	0.000295	CbGpPWpGaD
Captopril—ALB—Hemostasis—P2RY12—systemic lupus erythematosus	1.3e-05	0.000291	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	1.3e-05	0.000291	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL2—systemic lupus erythematosus	1.29e-05	0.000289	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—VEGFA—systemic lupus erythematosus	1.29e-05	0.000288	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—systemic lupus erythematosus	1.29e-05	0.000288	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—systemic lupus erythematosus	1.28e-05	0.000287	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	1.27e-05	0.000286	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.26e-05	0.000283	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.25e-05	0.000281	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	1.23e-05	0.000275	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	1.22e-05	0.000275	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NCF2—systemic lupus erythematosus	1.21e-05	0.000271	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LYN—systemic lupus erythematosus	1.2e-05	0.000269	CbGpPWpGaD
Captopril—ALB—Hemostasis—SELE—systemic lupus erythematosus	1.19e-05	0.000268	CbGpPWpGaD
Captopril—ALB—Hemostasis—CSK—systemic lupus erythematosus	1.19e-05	0.000268	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—systemic lupus erythematosus	1.18e-05	0.000265	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.18e-05	0.000264	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.18e-05	0.000264	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.18e-05	0.000264	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TLR9—systemic lupus erythematosus	1.15e-05	0.000257	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	1.14e-05	0.000257	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	1.14e-05	0.000255	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.13e-05	0.000254	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	1.12e-05	0.000252	CbGpPWpGaD
Captopril—ALB—Hemostasis—ITGAM—systemic lupus erythematosus	1.12e-05	0.000252	CbGpPWpGaD
Captopril—F2—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.11e-05	0.000249	CbGpPWpGaD
Captopril—ALB—Hemostasis—LYN—systemic lupus erythematosus	1.09e-05	0.000244	CbGpPWpGaD
Captopril—F2—Hemostasis—ALB—systemic lupus erythematosus	1.08e-05	0.000241	CbGpPWpGaD
Captopril—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	1.06e-05	0.000239	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.05e-05	0.000235	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.04e-05	0.000234	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	1.04e-05	0.000233	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EP300—systemic lupus erythematosus	1.03e-05	0.000232	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—systemic lupus erythematosus	1.03e-05	0.000231	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS3—systemic lupus erythematosus	1.03e-05	0.000231	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.02e-05	0.000229	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CSK—systemic lupus erythematosus	1.02e-05	0.000229	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	1.02e-05	0.000228	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.01e-05	0.000226	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	9.97e-06	0.000224	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—systemic lupus erythematosus	9.78e-06	0.000219	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	9.75e-06	0.000219	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.67e-06	0.000217	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.57e-06	0.000215	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.54e-06	0.000214	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JUNB—systemic lupus erythematosus	9.49e-06	0.000213	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—systemic lupus erythematosus	9.48e-06	0.000213	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.4e-06	0.000211	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NCF2—systemic lupus erythematosus	9.34e-06	0.000209	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—C3—systemic lupus erythematosus	9.32e-06	0.000209	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LYN—systemic lupus erythematosus	9.27e-06	0.000208	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.14e-06	0.000205	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.1e-06	0.000204	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CCL2—systemic lupus erythematosus	9.08e-06	0.000204	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RASGRP1—systemic lupus erythematosus	9.02e-06	0.000202	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—systemic lupus erythematosus	8.98e-06	0.000201	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PRL—systemic lupus erythematosus	8.74e-06	0.000196	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—systemic lupus erythematosus	8.72e-06	0.000196	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.66e-06	0.000194	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.53e-06	0.000191	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—C3—systemic lupus erythematosus	8.46e-06	0.00019	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—systemic lupus erythematosus	8.38e-06	0.000188	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	8.37e-06	0.000188	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	8.24e-06	0.000185	CbGpPWpGaD
Captopril—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	8.15e-06	0.000183	CbGpPWpGaD
Captopril—F2—Hemostasis—EP300—systemic lupus erythematosus	7.82e-06	0.000175	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.46e-06	0.000167	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—systemic lupus erythematosus	7.41e-06	0.000166	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JUNB—systemic lupus erythematosus	7.33e-06	0.000164	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	7.13e-06	0.00016	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.1e-06	0.000159	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JAK1—systemic lupus erythematosus	6.99e-06	0.000157	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.96e-06	0.000156	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.84e-06	0.000153	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—systemic lupus erythematosus	6.8e-06	0.000153	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—systemic lupus erythematosus	6.77e-06	0.000152	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	6.75e-06	0.000151	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PRL—systemic lupus erythematosus	6.75e-06	0.000151	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	6.71e-06	0.000151	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR5—systemic lupus erythematosus	6.63e-06	0.000149	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.62e-06	0.000149	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.53e-06	0.000146	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.5e-06	0.000146	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—C3—systemic lupus erythematosus	6.47e-06	0.000145	CbGpPWpGaD
Captopril—ALB—Hemostasis—JAK1—systemic lupus erythematosus	6.32e-06	0.000142	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	6.23e-06	0.00014	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.01e-06	0.000135	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	5.93e-06	0.000133	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	5.9e-06	0.000132	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	5.7e-06	0.000128	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.7e-06	0.000128	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—F2—systemic lupus erythematosus	5.68e-06	0.000128	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	5.62e-06	0.000126	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.51e-06	0.000124	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CD80—systemic lupus erythematosus	5.45e-06	0.000122	CbGpPWpGaD
Captopril—ALB—Metabolism—NAT2—systemic lupus erythematosus	5.43e-06	0.000122	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JAK1—systemic lupus erythematosus	5.4e-06	0.000121	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	5.23e-06	0.000117	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.15e-06	0.000116	CbGpPWpGaD
Captopril—ALB—Hemostasis—F2—systemic lupus erythematosus	5.14e-06	0.000115	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR5—systemic lupus erythematosus	5.12e-06	0.000115	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—systemic lupus erythematosus	5.07e-06	0.000114	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.04e-06	0.000113	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—systemic lupus erythematosus	5e-06	0.000112	CbGpPWpGaD
Captopril—F2—Signaling Pathways—C3—systemic lupus erythematosus	5e-06	0.000112	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.81e-06	0.000108	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	4.76e-06	0.000107	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TYK2—systemic lupus erythematosus	4.6e-06	0.000103	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOS3—systemic lupus erythematosus	4.52e-06	0.000101	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	4.49e-06	0.000101	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.32e-06	9.69e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CD80—systemic lupus erythematosus	4.21e-06	9.44e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS3—systemic lupus erythematosus	4.08e-06	9.15e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—systemic lupus erythematosus	3.91e-06	8.78e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.91e-06	8.78e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—systemic lupus erythematosus	3.83e-06	8.59e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.61e-06	8.1e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TYK2—systemic lupus erythematosus	3.55e-06	7.97e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOS3—systemic lupus erythematosus	3.49e-06	7.82e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—systemic lupus erythematosus	3.46e-06	7.76e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EP300—systemic lupus erythematosus	3.44e-06	7.71e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.4e-06	7.62e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.25e-06	7.3e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.24e-06	7.26e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—EP300—systemic lupus erythematosus	3.1e-06	6.96e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—RXRA—systemic lupus erythematosus	3.05e-06	6.83e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.02e-06	6.78e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.99e-06	6.7e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—systemic lupus erythematosus	2.96e-06	6.63e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—systemic lupus erythematosus	2.94e-06	6.6e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	2.94e-06	6.59e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.83e-06	6.34e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—systemic lupus erythematosus	2.8e-06	6.28e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.79e-06	6.25e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	2.7e-06	6.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	2.67e-06	5.99e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EP300—systemic lupus erythematosus	2.65e-06	5.95e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.52e-06	5.64e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.51e-06	5.63e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.31e-06	5.17e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—systemic lupus erythematosus	2.25e-06	5.05e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARG—systemic lupus erythematosus	1.92e-06	4.32e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—systemic lupus erythematosus	1.74e-06	3.9e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.69e-06	3.78e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.65e-06	3.71e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.59e-06	3.56e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.52e-06	3.4e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.51e-06	3.39e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.45e-06	3.25e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.43e-06	3.2e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.37e-06	3.06e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.33e-06	2.97e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—EP300—systemic lupus erythematosus	1.26e-06	2.82e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.25e-06	2.8e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.1e-06	2.47e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.04e-06	2.33e-05	CbGpPWpGaD
